ru en

The official website of the manufacturer - RITM OKB ZAO

Please, enter your name
Please, enter your phone number
Please, enter your e-mail Error in e-mail
Please, enter your message

+7 (8634) 315-698   (ext 101)

+7(909)4001013 (WhatsApp)

SCENAR and DENAS have united!

For many years RITM OKB ZAO and TRONITEK LLC have been developing and manufacturing medical devices based on the electric neurostimulation principle (RITM OKB ZAO has been creating SCENAR devices which use the principle of SCENAR therapy, while TRONITEK LLC has been producing DENAS devices which use the method of DENAS therapy).

denas
RITM OKB ZAO General director, Yury Starovoytov, and GC "SANED" President, Sergey Ryavkin

For all these years our companies have been effectively developing their electric neurostimulation approaches, our products have been recognized both in Russia and internationally, we gained great positive practical experience, and conducted many scientific and clinical studies which prove high efficiency and safety of our products. The products have received various quality awards and have been certified abroad.

In November 2018 TRONITEK LLC became RITM OKB ZAO distributor on exclusive terms. Moreover, the companies' management agreed to start a close cooperation in order to unite the accumulated experience for developing and selling innovative devices.

denas1
Yury Starovoytov and Sergey Ryavkin with a group of RITM OKB ZAO staff at the Medical Week 2018 trade fair

The very first device developed together will enter the European market under SCENAR trademark by the end of the year. Also, the joint medical training courses will be held in Europe this year, and in January 2019 the symposium with the participation of the medical representatives of two companies will take place in Ekaterinburg. And yet it is only the beginning of our partnership!

We are sure about our strategy. Uniting the efforts of two biggest manufacturers of portative medical physiotherapeutic devices will increase the global awareness of the electric neurostimulation method, create a greater variety of products developed by our companies, and, which is the most important, enable to start manufacturing new devices combining the advantages of SCENAR and DENAS therapy.

We wish all supporters of SCENAR and DENAS therapies to have a fruitful and positive teamwork in popularising this field of physiotherapy and to increase the volume of sales. On our part, we will put all possible efforts for developing and manufacturing new high efficiency and reliable devices.

Webinars

Consultations

Business